The Largest Study Conducted with Bionano’s Platform to Date Reveals Never-Before-Seen Human Genomic Structural Variations
05 mars 2019 08h00 HE
|
Bionano Genomics
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics
01 mars 2019 08h00 HE
|
Bionano Genomics
SAN DIEGO, March 01, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot
06 févr. 2019 08h00 HE
|
Bionano Genomics
SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications
14 janv. 2019 08h00 HE
|
Bionano Genomics
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables ultra-sensitive...
Bionano Genomics to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
25 oct. 2018 19h25 HE
|
Bionano Genomics
Call Scheduled for Wednesday, November 7th @ 4:30pm Eastern Time SAN DIEGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that...
Bionano and Genoox Launch Integrated Platform for Identification of Structural Variants in DNA
17 oct. 2018 11h00 HE
|
Bionano Genomics
SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
Bionano Genomics’ Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease
16 oct. 2018 15h00 HE
|
Bionano Genomics
SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
Bionano Genomics Announces the Separate Trading of Its Common Stock and Warrants
21 sept. 2018 08h00 HE
|
Bionano Genomics
SAN DIEGO, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...